Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …

Recent advances in the understanding and targeting of immune checkpoints have led to
great progress in immune therapies against many forms of cancer. While many types of …

Introduction Metastatic cutaneous squamous cell carcinoma (cSCC) is a very rare condition.
The lack of definition of an oligometastatic subgroup means that there is no consensus for its …

Cemiplimab has demonstrated relevant clinical activity in cutaneous squamous cell
carcinoma (cSCC) but mechanisms of primary and acquired resistance to immunotherapy …

Immunotherapeutic agents have revolutionized cancer treatment over the past decade.
However, most patients fail to respond to immunotherapy alone. A growing body of …

Simple Summary While surgery remains the main treatment modality for non-melanoma skin
cancer (NMSC), radiotherapy still plays a major role in the treatment algorithm, even with the …

Opinion statement The development of immunotherapies for nonmelanoma skin cancer
(NMSC) has lagged far behind that for melanoma in the past few decades, given that the …

Introduction: Cutaneous squamous cell carcinoma (cSCC) is one of the most frequently
occurring types of cancer in humans. Scientometric research is an innovative method for …

The objective of this study was to investigate the value of PET/CT imaging based on CNN
image registration algorithm in evaluating the short‐term efficacy of PD‐1 monoclonal …

Background Anti-PD1 agents are currently recommended as first-line treatment in advanced
cutaneous squamous cell carcinoma (acSCC) by updated European guidelines. Although …